TerminatedPhase 1NCT05084560
Development of AWZ1066S, a Small Molecule Anti-Wolbachia Candidate Macrofilaricide Drug
Studying Filariasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Liverpool School of Tropical Medicine
- Principal Investigator
- Graham Devereux, MDLiverpool School of Tropical Medicine
- Intervention
- AWZ1066S(drug)
- Enrollment
- 30 enrolled
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2021 – 2023
Study locations (1)
- Liverpool University Hospitals NHS Foundation Trust, Liverpool, Merseyside, United Kingdom
Collaborators
Liverpool University Hospitals NHS Foundation Trust · Covance · Subiaco Associates Limited · Sylexis Limited · Eisai Limited
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05084560 on ClinicalTrials.govOther trials for Filariasis
Additional recruiting or active studies for the same condition.